Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gulbu Uzel

Showing results (101-110 of 169) with videos related to

Pageof 17
Sort By:
The Journal of Allergy and Clinical Immunology|June 4, 2021
Nodular regenerative hyperplasia in X-linked agammaglobulinemia: An underestimated and severe complicationCristiane J Nunes-Santos, Christopher Koh, Anjali Rai, et al.
The Journal of Infectious Diseases|May 12, 2026
Cryptosporidiosis in inborn errors of immunity: a single center cohort and review of the literatureChen Wang, Evgenii Filippov, Amir Seyedmousavi, et al.
Open Forum Infectious Diseases|December 12, 2017
Risks of Ruxolitinib in <i>STAT1</i> Gain-of-Function-Associated Severe Fungal DiseaseOfer Zimmerman, Berenice Rösler, Christa S Zerbe, et al.
The Journal of Infectious Diseases|May 10, 2020
Patients With Natural Killer (NK) Cell Chronic Active Epstein-Barr Virus Have Immature NK Cells and Hyperactivation of PI3K/Akt/mTOR and STAT1 PathwaysMatthew K Howe, Kennichi Dowdell, Hye Sun Kuehn, et al.
The Journal of Allergy and Clinical Immunology|January 14, 2018
Mutations in PI3K110δ cause impaired natural killer cell function partially rescued by rapamycin treatmentRaquel Ruiz-García, Alexander Vargas-Hernández, Ivan K Chinn, et al.
Blood|November 18, 2022
A randomized, placebo-controlled phase 3 trial of the PI3Kδ inhibitor leniolisib for activated PI3Kδ syndromeV Koneti Rao, Sharon Webster, Anna Šedivá, et al.
Human Mutation|July 24, 2010
A custom 148 gene-based resequencing chip and the SNP explorer software: new tools to study antibody deficiencyHong-Ying Wang, Vivek Gopalan, Ivona Aksentijevich, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 9, 2016
Progressive Multifocal Leukoencephalopathy in Primary Immune Deficiencies: Stat1 Gain of Function and Review of the LiteratureChrista S Zerbe, Beatriz E Marciano, Rohit K Katial, et al.
The Journal of Allergy and Clinical Immunology|May 7, 2014
Somatic reversion in dedicator of cytokinesis 8 immunodeficiency modulates disease phenotypeHuie Jing, Qian Zhang, Yu Zhang, et al.
Cell Reports|October 13, 2021
PI3Kδ coordinates transcriptional, chromatin, and metabolic changes to promote effector CD8<sup>+</sup> T cells at the expense of central memoryJennifer L Cannons, Alejandro V Villarino, Senta M Kapnick, et al.
Pageof 17

Showing results (101-110 of 169) with videos related to

Sort By:
Pageof 17
The Journal of Allergy and Clinical Immunology|June 4, 2021
Nodular regenerative hyperplasia in X-linked agammaglobulinemia: An underestimated and severe complicationCristiane J Nunes-Santos, Christopher Koh, Anjali Rai, et al.
The Journal of Infectious Diseases|May 12, 2026
Cryptosporidiosis in inborn errors of immunity: a single center cohort and review of the literatureChen Wang, Evgenii Filippov, Amir Seyedmousavi, et al.
Open Forum Infectious Diseases|December 12, 2017
Risks of Ruxolitinib in <i>STAT1</i> Gain-of-Function-Associated Severe Fungal DiseaseOfer Zimmerman, Berenice Rösler, Christa S Zerbe, et al.
The Journal of Infectious Diseases|May 10, 2020
Patients With Natural Killer (NK) Cell Chronic Active Epstein-Barr Virus Have Immature NK Cells and Hyperactivation of PI3K/Akt/mTOR and STAT1 PathwaysMatthew K Howe, Kennichi Dowdell, Hye Sun Kuehn, et al.
The Journal of Allergy and Clinical Immunology|January 14, 2018
Mutations in PI3K110δ cause impaired natural killer cell function partially rescued by rapamycin treatmentRaquel Ruiz-García, Alexander Vargas-Hernández, Ivan K Chinn, et al.
Blood|November 18, 2022
A randomized, placebo-controlled phase 3 trial of the PI3Kδ inhibitor leniolisib for activated PI3Kδ syndromeV Koneti Rao, Sharon Webster, Anna Šedivá, et al.
Human Mutation|July 24, 2010
A custom 148 gene-based resequencing chip and the SNP explorer software: new tools to study antibody deficiencyHong-Ying Wang, Vivek Gopalan, Ivona Aksentijevich, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 9, 2016
Progressive Multifocal Leukoencephalopathy in Primary Immune Deficiencies: Stat1 Gain of Function and Review of the LiteratureChrista S Zerbe, Beatriz E Marciano, Rohit K Katial, et al.
The Journal of Allergy and Clinical Immunology|May 7, 2014
Somatic reversion in dedicator of cytokinesis 8 immunodeficiency modulates disease phenotypeHuie Jing, Qian Zhang, Yu Zhang, et al.
Cell Reports|October 13, 2021
PI3Kδ coordinates transcriptional, chromatin, and metabolic changes to promote effector CD8<sup>+</sup> T cells at the expense of central memoryJennifer L Cannons, Alejandro V Villarino, Senta M Kapnick, et al.
Pageof 17